10058-F4 is primarily used in biochemical research to study the mechanisms of cancer cell growth and apoptosis. It functions as a c-Myc inhibitor, targeting the c-Myc transcription factor, which plays a critical role in cell proliferation and survival. By inhibiting c-Myc, this compound helps researchers understand its role in tumorigenesis and explore potential therapeutic strategies for cancers where c-Myc is overexpressed. Additionally, it is utilized in laboratory settings to investigate the effects of c-Myc downregulation on various cellular processes, including metabolism, differentiation, and cell cycle progression. Its application is mainly confined to in vitro studies and preclinical research, contributing to the development of novel cancer treatments.